BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP – Regeneron Pharmaceuticals, Inc. Transaction History
BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP portfolio value:
$7.36M
portfolio value
BRITISH COLUMBIA INVESTMENT MANAGEMENT CORP quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -13.65% | -1.69K shares | 46K | $688.87 | 10.68K |
| Q2 2022 | share | Decrease | -24.16% | -3.94K shares | -4.08M | $591.13 | 12.37K |
| Q1 2022 | share | Decrease | -11.63% | -2.14K shares | -264K | $698.42 | 16.32K |
| Q4 2021 | share | Decrease | -4.63% | -897 shares | -56K | $642.51 | 18.46K |
| Q3 2021 | share | Decrease | -0.64% | -124 shares | 834K | $605.18 | 19.36K |
| Q2 2021 | share | Increase | +13.25% | 2.28K shares | 2.74M | $558.54 | 19.48K |
| Q1 2021 | share | Decrease | -2.73% | -483 shares | -405K | $473.14 | 17.20K |
| Q4 2020 | share | Increase | +1.13% | 198 shares | -1.24M | $483.11 | 17.69K |
| Q3 2020 | share | Increase | +8.23% | 1.33K shares | -287K | $559.78 | 17.49K |
| Q2 2020 | share | Increase | +82.51% | 7.30K shares | 5.75M | $623.65 | 16.16K |
| Q1 2020 | share | Decrease | -53.64% | -10.24K shares | -2.84M | $488.29 | 8.85K |
| Q4 2019 | share | Increase | +71.71% | 7.97K shares | 4.08M | $375.48 | 19.10K |
| Q3 2019 | share | Decrease | -57.69% | -15.16K shares | -5.14M | $277.4 | 11.12K |
| Q2 2019 | share | Decrease | -24.01% | -8.30K shares | -5.97M | $313 | 26.29K |
| Q1 2019 | share | Decrease | -1.51% | -532 shares | 1.08M | $410.62 | 34.59K |
| Q4 2018 | share | Increase | +5.84% | 1.94K shares | -289K | $373.5 | 35.13K |
| Q3 2018 | share | Decrease | -21.59% | -9.13K shares | -1.19M | $404.04 | 33.19K |
| Q2 2018 | share | Decrease | -35.50% | -23.29K shares | -7.99M | $344.99 | 42.33K |
| Q1 2018 | share | Decrease | -0.36% | -237 shares | -2.16M | $344.36 | 65.62K |
| Q4 2017 | share | Increase | +16.15% | 9.15K shares | -593K | $375.96 | 65.86K |
| Q3 2017 | share | Increase | +6.57% | 3.49K shares | -779K | $447.12 | 56.70K |
| Q2 2017 | share | Decrease | -5.15% | -2.89K shares | 4.39M | $491.14 | 53.20K |
| Q1 2017 | share | Increase | +33.25% | 13.99K shares | 6.28M | $387.51 | 56.09K |
| Q4 2016 | share | Increase | +13.54% | 5.02K shares | 548K | $367.09 | 42.10K |
| Q3 2016 | share | Decrease | -13.95% | -6.01K shares | -142K | $402.02 | 37.08K |
| Q2 2016 | share | 0.00% | 0 shares | -483K | $349.23 | 43.09K | |
| Q1 2016 | share | Increase | +3.61% | 1.5K shares | -7.04M | $360.44 | 43.09K |